相关实验视频
Updated: Jul 5, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
利尿剂和心律失常死亡的风险在左心室功能障碍的患者
H A Cooper1, D L Dries, C E Davis
1Clinical Trials Scientific Research Group, Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA. Cooperh@nih.gov
Circulation
|September 24, 1999
概括
非节性利尿剂增加了心律失常死亡的风险,在患有缩左心室功能障碍的患者. 节利尿剂在SOLVD研究中没有显示这种关联.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 利尿剂的使用与高血压患者心律失常死亡风险的增加有关.
- 利尿剂治疗对左心室功能障碍患者心律失常死亡的影响尚不清楚.
研究的目的:
- 为了研究基线尿液使用与心律失常死亡的风险之间的关系,在患有缩左心室功能障碍的患者.
主要方法:
- 从左心室功能障碍研究 (SOLVD) 队列中对6797名患者进行了回顾性分析.
- 评估了基线的利尿剂使用和随后的不律性死亡事件.
- 在统计分析中对相关共变量进行控制.
主要成果:
- 基线时的利尿剂使用与较高的节律失常死亡率有关 (3.1对1.7每100人年,P=0.001).
- 非节性利尿剂的使用独立增加了心律失常死亡风险 (RR 1.33,P=0.02).
- 单独或联合使用节约性利尿剂并没有独立地与心律失常死亡风险的增加有关 (RR 0.90,P=0.6).
结论:
- 基线使用非节约性利尿剂与心律失常死亡风险增加有关,在患有缩左心室功能障碍的患者中.
- 节性利尿剂与这种风险增加无关.
- 尿液诱导的电解质失衡可能会导致这种患者群体的致命性心律失常.
相关概念视频
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...

